Science for longer, healthier lives
Pipeline

Our pipeline

Programs from preclinical research to approval. Filter by therapeutic area or phase.

Home/Pipeline
4 programs
Program
PreclinicalPhase 1Phase 2Phase 3FiledApproved
Next milestone
CLV-147Ovarian cancerOncology · ADC
Phase 1
Dose escalation complete
CLV-233LupusImmunology · Cell therapy
Phase 1
First patient dosed
CLV-427Lp(a) elevationCardiometabolic · RNA
Phase 1
Single ascending dose complete
CLV-515Fabry diseaseRare Disease · RNA
Phase 1
First cohort dosed

Pipeline as of September 30, 2026. Programs and data are fictional.